Ondansetron Tablet, Orally Disintegrating
Product Images NDC 51655-196

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Ondansetron (NDC 51655-196). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northwind Health Company, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (51655 196 80)

This is a package of Ondansetron Orally Disintegrating Tablets, USP 8mg. It contains 8 tablets and is intended only for prescription use. The blister pack should not be removed until immediately before use and should not be used if the blisters are torn, broken or missing. The package is child-resistant and should be stored at controlled room temperature between 15°-30°C (59°-86°F). The package includes information about the manufacturer, repackaging details, and expiration date. The tablets should be kept out of reach of children, and phenylketonurics should be aware that it contains 3.37 mg of phenylalanine per tablet.*

FDA Label Image

Chemical Structure (Ondansetronod Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.